2007 Report to the commissioner of baseball of an independent investigation into the illegal use of steroids and other performance enhancing substances by players in major league baseball - Mitchell Report

Report to the commissioner of baseball of an independent investigation into the illegal use of steroids and other performance enhancing substances by players in major league baseball / George J. Mitchell. - Office of the Commissioner of Baseball, 2007



The Report, informally known as the "Mitchell Report," is the result of former Democratic United States Senator from Maine George J. Mitchell's 21-month investigation into the use of anabolic steroids and human growth hormone (HGH) in Major League Baseball (MLB). The 409-page report, released on December 13, 2007, covers the history of the use of illegal performance-enhancing substances by players and the effectiveness of the MLB Joint Drug Prevention and Treatment Program. The report also advances certain recommendations regarding the handling of past illegal drug use and future prevention practices. In addition, the report names 89 MLB players who are alleged to have used steroids or other performance-enhancing drugs.

The report describes motivations for its preparation, including health effects of steroids, legal issues, fair play, and reports that baseball players acted as role models for child athletes. For example, after news coverage in August 1998 that Mark McGwire had used the then-legal androstenedione, a steroid precursor, sales of the supplement increased over 1000%, and the National Institute on Drug Abuse reported that 8% of male high school senior athletes had used androstenedione in 2001.

Mitchell reported that during the random testing in 2003, 5 to 7 percent of players tested positive for steroid use. Players on the forty-man roster of major league teams were exempt from testing until 2004. One player is quoted: "Forty-man [roster] guys already have all of the [major league] club advantages, and then they could use steroids . . . it was not a level playing field."

According to the report, after mandatory random testing began in 2004, HGH became the substance of choice among players, as it was not then detectable in tests. Also, it was noted that at least one player from each of the thirty Major League Baseball teams was involved in the alleged violations

Original document

Parameters

Education
Elite Athletes
Date
13 December 2007
People
Mitchell, George J.
Original Source
Major League Baseball (MLB)
Country
United States of America
Language
English
ADRV
Administration / attempted administration
Complicity
Possession
Trafficking / attempted trafficking
Use / attempted use
Legal Terms
Admission
Affidavit
Anti-Doping policy
Circumstantial evidence
Criminal case / judicial inquiry
Digital evidence / information
Period of ineligibility
Rules & regulations National Sports Organisations & National Anti-Doping Organisations
Substantial assistance
Sport/IFs
Baseball-Softball (WBSC) - World Baseball-Softball Confederation
Other organisations
Major League Baseball (MLB)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Analytical aspects
No specific test for substance
Doping classes
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
S6. Stimulants
S9. Glucocorticosteroids
Substances
Androstenedione (androst-4-ene-3,17-dione)
Clenbuterol
Cocaine
Growth hormone (GH)
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Nandrolone (19-nortestosterone)
Oxandrolone
Oxymetholone
Stanozolol
Testosterone
Various
Athlete support personnel
BALCO affair
Doping control
Doping culture
Illegal production / trade
Lying / false statement
Mitchell reports
Publicity / public disclosure
Sports officials
Document category
Report
Document type
Pdf file
Date generated
14 September 2015
Date of last modification
14 September 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin